Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles

References

• Batycky RP, Hanes J, Langer R, Edwards DA. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci 1997; 86: 1464–1477
   PubMed Web of Science ®Google Scholar
• Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: Effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm 1998; 45: 285–294
   PubMed Web of Science ®Google Scholar
• Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int J Biochem Cell Biol 2001; 33: 357–369
   PubMed Web of Science ®Google Scholar
• Cao Y. Tumor angiogenesis and therapy. Biomed Pharmacother 2005; 59(Suppl 2)S340–S343
   Google Scholar
• Carrasquillo KG, Stanley AM, Aponte JC. Non-aqueous encapsulation of excipient-stabilized spray freeze-dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Contr Rel 2001; 76: 199–208
   PubMed Web of Science ®Google Scholar
• Csaba N, Caamaño P, Sanchez A, Domínguez F, Alonso MJ. PLGA:Poloxamer and PLGA:Poloxamine blend nanoparticles: New carriers for gene delivery. Biomacromolecules 2005; 6: 271–278
   PubMed Web of Science ®Google Scholar
• Csaba N, Gonzalez L, Sanchez A, Alonso MJ. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J Biomater Sci Polym Ed 2004; 15: 1137–1151
   PubMed Web of Science ®Google Scholar
• Csaba N, Sánchez A, Alonso MJ. PLGA:Poloxamer and PLGA:Poloxamine blend nanostructures as carriers for nasal gene delivery. J Contr Rel 2006; 113: 164–172
   PubMed Web of Science ®Google Scholar
• Daviesa GL, Barrya A, Gun’ko YK. Preparation and size optimisation of silica nanoparticles using statistical analyses. Chem Phys Lett 2009; 468: 239–244
   Google Scholar
• Fazekas K, Janovics A, Döme B, Koska P, Albini A, Tímár J. Effect of HGF-like basic hexapepetides on angiogenesis. Microvasc Res 2001; 62: 440–444
   PubMedGoogle Scholar
• Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967–974
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182–1186
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis. Annu Rev Med 2006; 57: 1–18
   PubMed Web of Science ®Google Scholar
• Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000; 17: 100–106
   PubMed Web of Science ®Google Scholar
• Horváth A, Vántus T, Seprödi J, Okada Y, Tsuda Y, Miyazaki A, et al. Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds. Hungarian patent application: HU07/28989 2007
   Google Scholar
• Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(Dl-lactide-co-glycolide). J Microencapsulation 2005; 22: 593–601
   PubMed Web of Science ®Google Scholar
• Jiang W, Schwendeman SP. Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. J Pharm Sci 2001; 90: 1558–1569
   PubMed Web of Science ®Google Scholar
• Kissel T, Koneberg R, Hilbert AK, Hungerer KD. Microencapsulation of antigens using biodegradable polyesters: Facts and phantasies. Behring Inst Mitt 1997; 98: 172–183
   Google Scholar
• Kobayashi H, Lin PC. Nanotechnology for antiangiogenic cancer therapy. Nanomedicine 2006; 1: 17–22
   PubMedGoogle Scholar
• Lamprecht A, Ubrich N, Hombreiro Perez M, Lehr CM, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm 2000; 196: 177–182
   PubMed Web of Science ®Google Scholar
• Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, et al. Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol 2000; 18: 2593–2602
   PubMed Web of Science ®Google Scholar
• Moghimi SM. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anticancer Agents Med Chem 2006; 6: 553–561
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Contr Rel 2008; 126: 246–254
   PubMed Web of Science ®Google Scholar
• O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277–285
   PubMed Web of Science ®Google Scholar
• Ringseis R, Matthes B, Lehmann V, Schöps R, Ulbrich-Hofmann R, Eder K. Peptides and hydrolisates from casein and soy protein modulate the release of vasoactive substances from human aortic endothelial cells. Biochim Biophys Acta 2005; 1721: 89–97
   PubMedGoogle Scholar
• Sah H, Toddywala R, Chien YW. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J Contr Rel 1994; 30: 201–211
   Web of Science ®Google Scholar
• Sanchez A, Tobio M, Gonzalez L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003; 18: 221–229
   PubMed Web of Science ®Google Scholar
• Sanchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm 1999; 185: 255–266
   PubMed Web of Science ®Google Scholar
• Santander-Ortega MJ, Jódar-Reyes AB, Csaba N, Bastos-González D, Ortega-Vinuesa JL. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilisation mechanisms. J Colloid Interface Sci 2006; 302: 522–529
   PubMed Web of Science ®Google Scholar
• Sebti SM, Hamilton AD. Design of growth factor antagonists with antiangiogenic and antitumor properties. Oncogene 2000; 19: 6566–6573
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Rel 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, et al. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 2007; 66: 488–492
   PubMed Web of Science ®Google Scholar
• Tobio M, Nolley J, Guo Y, Mc Iver J, Alonso MJ. A novel system based on a Poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm Res 1999; 16: 682–688
   PubMed Web of Science ®Google Scholar
• Varga A, Horváth A, Seprődi J, Vántus T, Tanai H, Szolcsányi J, et al. Effect of somatostatin drived peptides and peptidomimetics on neurogenic inflammation. J Pept Sci 2008; 14(Suppl 8)127
   PubMedGoogle Scholar
• Yance DR Jr, Sagar SM. Targeting angiogenesis with integrative cancer therapies. Integr Cancer Ther 2006; 5: 9–29
   PubMedGoogle Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004; 27: 1–12
   PubMed Web of Science ®Google Scholar
• Zidan AS, Sammour OA, Hammad MA, Megrab NA. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. AAPS Pharm Sci Tech 2006; 7: 61–69
   PubMed Web of Science ®Google Scholar